Doctors
Dermatologist and Medical Oncologist | Melanoma and Skin Tumors
Dr. Mor Miodovnik is a dermatologist and medical oncologist with a clinical focus on melanoma and skin malignancies. Her work combines dermatologic expertise with oncology care, allowing for comprehensive evaluation and management of patients with suspicious skin lesions and confirmed skin cancers.
A significant part of her practice involves early detection of melanoma and monitoring individuals at increased risk for developing skin cancer. She also manages patients with rare skin tumors and advanced melanoma, tailoring treatment strategies based on disease characteristics and patient needs.
Dr. Miodovnik’s clinical approach includes dermoscopic evaluation, risk assessment, and coordination of modern oncologic treatments when necessary.
Clinical Focus
- Melanoma
• Skin malignancies
• Rare skin tumors
• Dermoscopic evaluation
• Early detection of skin cancer
• High-risk patient monitoring
• Advanced melanoma
• Systemic treatment approaches
Education
MD-PhD Track, Sackler Faculty of Medicine, Tel Aviv University, Israel
Clinical Training
- Research Fellowship, University Hospital Schleswig-Holstein, Lübeck, Germany
Focus: Immunogenetics and skin microbiome
Clinical Experience
- Head of Melanoma and Skin Tumors Service, Tel Aviv Medical Center, Since 2021
- Medical Oncologist — Skin Tumors Clinic, Tel Aviv Medical Center
- Senior Dermatology Physician — Melanoma Surveillance Clinic, Tel Aviv Medical Center
- Dermatology Residency, Tel Aviv Medical Center
Academic and Research Activity
Dr. Miodovnik has contributed to scientific research in melanoma and skin cancer and has participated in international medical conferences.
Her research interests include melanoma biology, personalized treatment strategies, and emerging therapies in skin oncology.
Clinical Interests
- Melanoma diagnosis
• Pigmented lesion assessment
• Skin cancer prevention
• High-risk patient follow-up
• Rare skin tumors
• Advanced melanoma
Professional Activity
Dr. Mor Miodovnik evaluates patients with suspicious skin lesions and provides follow-up for individuals with melanoma and other skin cancers. She is involved in the management of both early-stage and advanced disease.
Her clinical work includes dermoscopy, clinical risk assessment, and multidisciplinary care when needed.
Frequently Asked Questions
1.What is basal cell carcinoma?
I see basal cell carcinoma very often. Many patients come in thinking it’s just a small spot that doesn’t heal. Sometimes it’s a shiny bump, sometimes a small pink area — it doesn’t always look alarming at first.
In most cases, basal cell carcinoma grows slowly. It usually doesn’t spread to other organs, but over time it can damage nearby tissue if we ignore it. That’s why early evaluation matters.
Treatment is usually straightforward, especially when we detect it early. The exact approach depends on the size, location, and a few other clinical factors.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
2. What is squamous cell carcinoma?
Squamous cell carcinoma is a bit different. It can behave more aggressively than basal cell carcinoma, especially if diagnosis is delayed.
Patients often describe a rough patch, a lesion that keeps coming back, or a spot that starts bleeding. Sometimes it’s tender. Sometimes not. It can vary quite a bit.
The good news is that when we detect it early, treatment is usually very effective. The treatment plan depends on the size, location, and whether the tumor has spread.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
3. What is melanoma?
Melanoma is the type of skin cancer that concerns patients the most — and understandably so. It can behave more aggressively than other skin cancers.
Often, patients notice changes in a mole. Sometimes a new lesion appears. Not every mole is dangerous, but if something looks different — it’s worth checking.
When melanoma is detected early, outcomes are usually very good. If diagnosed later, treatment becomes more complex and may involve systemic therapies.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
4. What is cutaneous lymphoma?
Cutaneous lymphoma is relatively rare. Patients often come in thinking it’s eczema or another skin condition, because it can look similar.
Some types progress slowly and may not require immediate treatment. Others behave differently and need a more active approach. This really depends on the specific subtype.
Because of this variability, diagnosis and management usually require careful evaluation.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
5. What is Merkel cell carcinoma?
Merkel cell carcinoma is rare, but it tends to grow quickly. Patients usually notice a small lump that increases in size over a short period of time.
Because this tumor can behave aggressively, early evaluation is important. Treatment decisions depend on several factors, including tumor size and stage.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
There are no reviews yet. Be the first one to write one.